Guideline News August 2023 here
Guideline News August 2023
Posted: Monday, September 11, 2023
Category - Medicines Update
Posted: Monday, September 11, 2023
Category - Medicines Update
Guideline News August 2023 here
Posted: Friday, September 8, 2023
Category - Medicines Update
New NHSGGC Guideline - Tetracycline and Fluoroquinolone Antibiotic Interactions here
New NHSGGC guideline to help raise awareness and management of the interaction between oral tetracycline and fluoroquinolone antibiotics with multivalent cation-containing products (e.g. iron and calcium)
Posted: Wednesday, September 6, 2023
Category - Medicines Update
Key Medicine Shortages September 2023 here
Includes: Disulfiram, Jext (adrenaline), Phenytoin sodium, Pilocarpine hydrochloride, Minims® Povidone Iodine, Reboxetine (Edronax®), Tacrolimus (Adoport®), Tacrolimus (Dailiport®), Rifampicin 150mg/Isoniazid 75mg/Pyrazinamide 400mg/Ethambutol 275mg (Voractiv®), products used in the treatment of scabies: Permethrin 5% dermal cream (Lyclear®) and Malathion 0.5% liquid
Posted: Wednesday, September 6, 2023
Category - Medicines Update
MHRA Drug Safety Update August 2023 here
Posted: Sunday, August 27, 2023
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary
Posted: Friday, August 18, 2023
Category - Medicines Update
Medicines linked to falls here
Certain drug classes and combinations of medicines confer greater risk for frail patients than the general adult population. Any medicine which can cause sedation, hypotension or hypoglycaemia can increase risk of falls.
Posted: Tuesday, August 8, 2023
Category - Medicines Update
Guideline News July 2023 here
Posted: Tuesday, August 8, 2023
Category - Medicines Update
Off-label or unlicensed use of medicines here.
The MHRA and the NHS Circular PCA(P)(2015)17 recommend that ‘specials’ and imported unlicensed medicines should only be used where there is no suitable licensed alternative. Clinicians should not routinely use an unlicensed preparation when there is a licensed product available, unless there is a specific clinical reason.
Posted: Tuesday, August 8, 2023
Category - Medicines Update
Suspected defective medicines policy here
Guidance for reporting a suspected defective medicine is provided within this policy,
along with a reporting form. These can be found via GGC Medicines: Medicines Policies
under the miscellaneous section (8.1 and 8.1.1).
Posted: Monday, August 7, 2023
Category - Medicines Update
MHRA Drug Safety Update July 2023 here